Zurück
hat etwas gedauert, aber doch....
Anzeige
Meldung des Tages: SGS liefert den Ritterschlag: Weltklasse-Tests machen aus einem Explorer plötzlich ein Industrie-Asset
Savient Pharmaceuticals (WKN 813149)
Beiträge:
55
Zugriffe: 10.099 / Heute: 1
Zugriffe: 10.099 / Heute: 1
|
Werbung
Entdecke die beliebtesten ETFs von Amundi
Lyxor Net Zero 2050 S&P World Climate PAB (DR) UCITS ETF Acc
Perf. 12M: +206,18%
Amundi IBEX 35 Doble Apalancado Diario (2x) UCITS ETF Acc
Perf. 12M: +121,39%
Amundi MSCI Greece UCITS ETF Dist
Perf. 12M: +58,48%
Amundi IBEX 35 UCITS ETF Dist
Perf. 12M: +53,60%
Amundi IBEX 35 UCITS ETF Acc
Perf. 12M: +53,23%
Die Reise ist aber noch lange nicht vorbei.....
denkt an meine Worte.....
denkt an meine Worte.....
F***, war leider kein Zulassungszock!
FDA says Savient must address manufacturing issues for gout drug Krystexxa before approval
Obwohl hier kurzfristig über 150% möglich gewsesen sind, siehe Threadperformance, macht die FDA einen Strich durch die Rechnung!
Shares fell $5.89, or 38 percent, to $9.70 in premarket trading.
Schade, auf zum nächsten Zock!
http://finance.yahoo.com/news/...-FDA-rejects-apf-1803540982.html?x=0
FDA says Savient must address manufacturing issues for gout drug Krystexxa before approval
Obwohl hier kurzfristig über 150% möglich gewsesen sind, siehe Threadperformance, macht die FDA einen Strich durch die Rechnung!
Shares fell $5.89, or 38 percent, to $9.70 in premarket trading.
Schade, auf zum nächsten Zock!
http://finance.yahoo.com/news/...-FDA-rejects-apf-1803540982.html?x=0
Ich hoffe du bist in dem scheiss nicht investiert,ich habe nie verstanden,warum Savient so hoch bewertet war ....
MFg
Chali
MFg
Chali
Schade trotzdem!
lg
Der heutige Tag ist nicht meiner.....
lg
Der heutige Tag ist nicht meiner.....
de.advfn.com/...&t=17&dm=0&vol=1&cb=1136389482
Savient jumps 14% after earnings report
BOSTON (MarketWatch) -- Shares of Savient Pharmaceuticals SVNT +15.95% jumped 14% to 66 cents a share on Wednesday after the biotech group posted a narrowed second-quarter loss. The stock has risen 8% over the last 30 days but has plunged 70% since the beginning of the year. Earlier this week, Savient adopted a shareholders rights plan to deter a possible hostile takeover by stakeholder Tang Capital Partners. Earlier this year, Tang had asserted that Savient was insolvent. On Wednesday, Savient stated it ended the second quarter with $142.2 million in cash and short-term securities. Savient's revenues largely come from its recently approved gout drug Krystexxa, which had sales of $4 million for the second quarter.
www.marketwatch.com/story/...s-report-2012-08-08?siteid=yhoof2
BOSTON (MarketWatch) -- Shares of Savient Pharmaceuticals SVNT +15.95% jumped 14% to 66 cents a share on Wednesday after the biotech group posted a narrowed second-quarter loss. The stock has risen 8% over the last 30 days but has plunged 70% since the beginning of the year. Earlier this week, Savient adopted a shareholders rights plan to deter a possible hostile takeover by stakeholder Tang Capital Partners. Earlier this year, Tang had asserted that Savient was insolvent. On Wednesday, Savient stated it ended the second quarter with $142.2 million in cash and short-term securities. Savient's revenues largely come from its recently approved gout drug Krystexxa, which had sales of $4 million for the second quarter.
www.marketwatch.com/story/...s-report-2012-08-08?siteid=yhoof2
CEO Discusses Q2 2012 Results - Earnings Call Transcript
seekingalpha.com/article/...nings-call-transcript?source=yahoo
seekingalpha.com/article/...nings-call-transcript?source=yahoo
Aus der heutige Sicht, sieht es doch sehr attraktiv aus. IMO
Bin gespannt.
GLTA ;)
Bristol-Myers Squibb Co. and Novartis AG both looked at acquiring Savient and passed because of concern about price, according to two people with knowledge of the matter, who declined to be identified because the talks are private. The board of directors will continue to “evaluate strategic alternatives,” Savient said in a statement today.
www.bloomberg.com/news/2010-10-25/...g-company.html?cmpid=yhoo
messages.finance.yahoo.com/Stocks_(A_to_Z)/...tof=15&frt=2
Bin gespannt.
GLTA ;)
Bristol-Myers Squibb Co. and Novartis AG both looked at acquiring Savient and passed because of concern about price, according to two people with knowledge of the matter, who declined to be identified because the talks are private. The board of directors will continue to “evaluate strategic alternatives,” Savient said in a statement today.
www.bloomberg.com/news/2010-10-25/...g-company.html?cmpid=yhoo
messages.finance.yahoo.com/Stocks_(A_to_Z)/...tof=15&frt=2
BlackRock Inc. hat aufgestockt!!
Amount beneficially owned:
3113521
Percent of class
4.27%
SC 13G/A amended statement of beneficial ownership 09-10-12
investor.savient.com/sec.cfm
Amount beneficially owned:
3113521
Percent of class
4.27%
SC 13G/A amended statement of beneficial ownership 09-10-12
investor.savient.com/sec.cfm
Sehr netter Seeking Alpha Artikel über die aktuelle Situation.
seekingalpha.com/article/...-rising-from-the-dead?source=yahoo
seekingalpha.com/article/...-rising-from-the-dead?source=yahoo
Whauuuuuu, zu Beginn sofort ein 400k Kauf!!!
Munter geht das Treiben weiter! ;)Zieehhhhh
Munter geht das Treiben weiter! ;)Zieehhhhh
Für einen Freitag ein verdammt guter Lauf.
After Hours: 2,54$
Volumen 13.600
www.nasdaq.com/symbol/svnt/after-hours
After Hours: 2,54$
Volumen 13.600
www.nasdaq.com/symbol/svnt/after-hours
Kommt sie heute, ich bin gespannt.
www.biopharmcatalyst.com/ema-calendar/
www.biopharmcatalyst.com/ema-calendar/
Savient Receives Positive CHMP Opinion for KRYSTEXXA® Approval in the EU
finance.yahoo.com/news/...positive-chmp-opinion-145000794.html
finance.yahoo.com/news/...positive-chmp-opinion-145000794.html
Es gibt keine neuen Beiträge.
|
Neueste Beiträge aus dem SAVIENT PHARMACEUTICALS INC Forum
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 71 | Savient Pharma. - Rebound eingeläutet? | Rudini | VeniceBeach | 06.01.14 16:50 | ||
| Die Tradingchance... | KILLERBABE | 16.12.13 20:38 | ||||
6 | 54 | Savient Pharmaceuticals (WKN 813149) | iceman78 | Joschi307 | 23.07.13 11:20 |